World's Best Scientists 2026 revealed!
Véronique Frémeaux-Bacchi

Véronique Frémeaux-Bacchi

D-Index & Metrics

Immunology

D-Index
105
Citations
38500
World Ranking
595
National Ranking
16

Medicine

D-Index
105
Citations
38549
World Ranking
6802
National Ranking
202

Véronique Frémeaux-Bacchi publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Véronique Frémeaux-Bacchi sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 441 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Véronique Frémeaux-Bacchi D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Véronique Frémeaux-Bacchi sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 105 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Véronique Frémeaux-Bacchi is affiliated with Inserm in France and has a significant body of research primarily in medicine and immunology. Their scholarly output spans 182 publications in medicine and 86 in immunology and microbiology. Within these broad fields, the scientist has contributed extensively to subfields such as immunology, nephrology, hematology, genetics, and infectious diseases.

The research focus concentrates on several key topics, prominently including:

  • Complement system in diseases
  • Renal diseases and glomerulopathies
  • Blood groups and transfusion
  • Renal transplantation outcomes and treatments
  • Platelet disorders and treatments
  • COVID-19 clinical research studies
  • Hemoglobinopathies and related disorders

Their work appears consistently in specialized journals, with the most frequent publication venues being:

  • Nephrology Dialysis Transplantation
  • Journal of the American Society of Nephrology
  • Kidney International Reports
  • Blood
  • Kidney International

Véronique Frémeaux-Bacchi collaborates regularly with several researchers, including:

  • Sophie Chauvet
  • Fádi Fakhouri
  • Lubka T. Roumenina
  • Anna Duval
  • Éric Rondeau

The scientist has contributed to multiple recent papers, notable among them:

  • Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept study (2020), published in EClinicalMedicine
  • Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study (2020), published in Blood
  • Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group (2020), published in Blood
  • Fatal thrombotic microangiopathy case following adeno-associated viral SMN gene therapy (2022), published in Blood Advances
  • Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics (2021), published in Nature Reviews Nephrology

Best Publications

  • Complement System Part I - Molecular Mechanisms of Activation and Regulation

    Nicolas S. Merle;Nicolas S. Merle;Nicolas S. Merle;Sarah Elizabeth Church;Sarah Elizabeth Church;Sarah Elizabeth Church;Veronique Fremeaux-Bacchi;Lubka T. Roumenina;Lubka T. Roumenina;Lubka T. Roumenina

  • Complement System Part II: Role in Immunity.

    Nicolas S. Merle;Remi Noe;Lise Halbwachs-Mecarelli;Veronique Fremeaux-Bacchi

  • Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival

    Alexandre Loupy;Carmen Lefaucheur;Dewi Vernerey;Christof Prugger

  • Genetics and Outcome of Atypical Hemolytic Uremic Syndrome: A Nationwide French Series Comparing Children and Adults

    Véronique Fremeaux-Bacchi;Fadi Fakhouri;Arnaud Garnier;Frank Bienaimé

  • Atypical hemolytic uremic syndrome

    Chantal Loirat;Véronique Frémeaux-Bacchi

  • Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

    Timothy H.J. Goodship;H. Terence Cook;Fadi Fakhouri;Fernando C. Fervenza

  • C3 glomerulopathy: consensus report

    Matthew C. Pickering;Vivette D. D'agati;Carla M. Nester;Richard J. Smith

  • An international consensus approach to the management of atypical hemolytic uremic syndrome in children.

    Chantal Loirat;Fadi Fakhouri;Gema Ariceta;Nesrin Besbas

  • Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies

    Aude Servais;Aude Servais;Laure-Hélène Noël;Lubka T. Roumenina;Moglie Le Quintrec

  • Haemolytic uraemic syndrome.

    Fadi Fakhouri;Julien Zuber;Véronique Frémeaux-Bacchi;Chantal Loirat

  • Anti–Factor H Autoantibodies Associated with Atypical Hemolytic Uremic Syndrome

    Marie-Agnès Dragon-Durey;Chantal Loirat;Sylvie Cloarec;Marie-Alice Macher

  • Pregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene Mutations

    Fadi Fakhouri;Lubka Roumenina;François Provot;Marion Sallée

  • Differential Impact of Complement Mutations on Clinical Characteristics in Atypical Hemolytic Uremic Syndrome

    Anne-Laure Sellier-Leclerc;Veronique Fremeaux-Bacchi;Marie-Agnès Dragon-Durey;Marie-Alice Macher

  • Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome

    Mathieu Lemaire;Véronique Frémeaux-Bacchi;Franz Schaefer;Murim Choi

  • Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies

    Julien Zuber;Fadi Fakhouri;Lubka T. Roumenina;Chantal Loirat

  • Heterozygous and Homozygous Factor H Deficiencies Associated with Hemolytic Uremic Syndrome or Membranoproliferative Glomerulonephritis: Report and Genetic Analysis of 16 Cases

    Marie-Agnès Dragon-Durey;Véronique Frémeaux-Bacchi;Chantal Loirat;Jacques Blouin

  • Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome

    V Fremeaux-Bacchi;MA Dragon-Durey;J Blouin;C Vigneau

  • Eculizumab in severe Shiga-toxin-associated HUS.

    Anne-Laure Lapeyraque;Michal Malina;Véronique Fremeaux-Bacchi;Tobias Boppel

  • C3 glomerulopathy: a new classification

    Fadi Fakhouri;Véronique Frémeaux-Bacchi;Laure-Hélène Noël;H Terence Cook

  • Endothelium structure and function in kidney health and disease

    Noemie Jourde-Chiche;Noemie Jourde-Chiche;Fadi Fakhouri;Laetitia Dou;Jeremy Bellien

  • ATYPICAL HEMOLYTIC UREMIC SYNDROME AND C3 GLOMERULOPATHY: CONCLUSIONS FROM A «KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES» (KDIGO) CONTROVERSIES CONFERENCE

    Timothy H.J. Goodship;H. Terence Cook;Fadi Fakhouri;Fernando C. Fervenza

Frequent Co-Authors

Marie-Agnès Dragon-Durey
Marie-Agnès Dragon-Durey Université Paris Cité
Chantal Loirat
Chantal Loirat Grenoble Alpes University
Timothy H.J. Goodship
Timothy H.J. Goodship Newcastle University
Marina Noris
Marina Noris Mario Negri Institute for Pharmacological Research
Wolf H. Fridman
Wolf H. Fridman Université Paris Cité
Catherine Sautès-Fridman
Catherine Sautès-Fridman Université Paris Cité
John P. Atkinson
John P. Atkinson Washington University in St. Louis
David J. Kavanagh
David J. Kavanagh Queensland University of Technology
Richard J.H. Smith
Richard J.H. Smith University of Iowa

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related health science degrees can open diverse career opportunities. Many professionals begin with strong foundational nursing qualifications. For non-nurses aiming to enter the field, online ADN programs for non nurses provide an accessible path to start a nursing career while developing essential clinical skills.

Nurses looking to specialize further might consider accelerated programs that fast-track their journey, such as the accelerated FNP options. These programs can help registered nurses transition quickly into family nurse practitioner roles, which often involve immunological knowledge to manage patient care.

Advancing from roles like Family Nurse Practitioner to more specialized positions requires additional credentials. Achieving acute care nurse practitioner certification is one such step, especially for those focused on critical care and immunological treatments in hospital settings.

Understanding compensation trends, such as through resources on DNP salary transparency, is crucial for making informed career decisions. Knowing salary ranges by state can guide professionals as they pursue advanced degrees and certifications linked to immunology-related healthcare roles.

Best Scientists Citing Véronique Frémeaux-Bacchi

Trending Scientists

Recently Published Articles